| 000 | 01694 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518065727.0 | ||
| 264 | 0 | _c20200403 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/s12885-019-6278-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHill, David P | |
| 245 | 0 | 0 |
_aCisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance. _h[electronic resource] |
| 260 |
_bBMC cancer _cNov 2019 |
||
| 300 |
_a1039 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiological Evolution |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aConserved Sequence |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGenomics _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Androgen _xmetabolism |
| 650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
| 700 | 1 | _aHarper, Akeena | |
| 700 | 1 | _aMalcolm, Joan | |
| 700 | 1 | _aMcAndrews, Monica S | |
| 700 | 1 | _aMockus, Susan M | |
| 700 | 1 | _aPatterson, Sara E | |
| 700 | 1 | _aReynolds, Timothy | |
| 700 | 1 | _aBaker, Erich J | |
| 700 | 1 | _aBult, Carol J | |
| 700 | 1 | _aChesler, Elissa J | |
| 700 | 1 | _aBlake, Judith A | |
| 773 | 0 |
_tBMC cancer _gvol. 19 _gno. 1 _gp. 1039 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-019-6278-9 _zAvailable from publisher's website |
| 999 |
_c30271683 _d30271683 |
||